The research group in Pulmonary and Cardiovascular Pharmacology is dedicated to advancing novel pharmacological approaches for the treatment of cardiovascular disease and sexual dysfunction, and treatment for patients with pulmonary diseases. Our work is translational at its core, bridging lab bench research to bedside application. We draw on diverse experience in pharmacological studies—from cell culture and patient- and animal-derived tissue samples to active participation in clinical studies. Our goal is to translate cutting-edge science into real-world therapies that improve patient outcomes.
